Matches in Nanopublications for { ?s ?p "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP896815.RAB7TVVUcVudBEhTUZzK80t7pOxpRnTAdLryeAk7PhmUk130_assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896815.RAB7TVVUcVudBEhTUZzK80t7pOxpRnTAdLryeAk7PhmUk130_provenance.
- assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP872758.RAzeyFZTDxZ31J59jqsNisYDL0RUjIiu_YAJvebADAdNI130_assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872758.RAzeyFZTDxZ31J59jqsNisYDL0RUjIiu_YAJvebADAdNI130_provenance.
- NP273684.RAoj66GyoeJKR0l3Q6igWeEnz5hd3c4HSV_N9HwB4TXMI130_assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273684.RAoj66GyoeJKR0l3Q6igWeEnz5hd3c4HSV_N9HwB4TXMI130_provenance.
- NP649974.RAAbF3hUmDrT_4e1ETihVcqihuGCT_AwcynjdTcRInFPY130_assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649974.RAAbF3hUmDrT_4e1ETihVcqihuGCT_AwcynjdTcRInFPY130_provenance.
- NP649973.RA2Akz9B0R6lNLA2oc9SCikAI8vscWeUm6XXX3Rhqiisk130_assertion description "[Women with a BRCA1 or BRCA2 mutation who had been diagnosed with unilateral breast cancer were followed prospectively for a minimum of 1.5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649973.RA2Akz9B0R6lNLA2oc9SCikAI8vscWeUm6XXX3Rhqiisk130_provenance.